{
  "ticker": "CSTL",
  "company_name": "Castle Biosciences, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT01858753",
      "title": "Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "Restrictive Burn Scars",
      "start_date": "2013-05",
      "completion_date": "2016-07",
      "enrollment": 0,
      "sponsor": "Castle Creek Biosciences, LLC."
    },
    {
      "nct_id": "NCT00620737",
      "title": "Pilot Safety and Efficacy Study of Isolagen Therapy in Treatment of Restrictive Burn Scars",
      "status": "WITHDRAWN",
      "phase": "PHASE2",
      "condition": "Restrictive Burn Scars of Joint Area",
      "start_date": "2008-02",
      "completion_date": "",
      "enrollment": 0,
      "sponsor": "Castle Creek Biosciences, LLC."
    },
    {
      "nct_id": "NCT02355587",
      "title": "Five Year Study to Track Use of DecisionDX-Melanoma Test in Patients With Cutaneous Melanoma and Associated Patient Outcomes",
      "status": "TERMINATED",
      "phase": "",
      "condition": "Cutaneous Melanoma",
      "start_date": "2014-03",
      "completion_date": "2021-07-31",
      "enrollment": 0,
      "sponsor": "Castle Biosciences Incorporated"
    },
    {
      "nct_id": "NCT06892639",
      "title": "Evaluation of D-Fi for the Treatment of Wounds Due to DEB",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Dystrophic Epidermolysis Bullosa",
      "start_date": "2025-03-27",
      "completion_date": "2042-02",
      "enrollment": 0,
      "sponsor": "Castle Creek Biosciences, LLC."
    },
    {
      "nct_id": "NCT00642642",
      "title": "Safety and Efficacy Study of Autologous Fibroblasts in the Treatment of Severe Facial Acne Scarring",
      "status": "COMPLETED",
      "phase": "PHASE2, PHASE3",
      "condition": "Acne Scarring of the Face",
      "start_date": "2007-11",
      "completion_date": "2009-03",
      "enrollment": 0,
      "sponsor": "Castle Creek Biosciences, LLC."
    },
    {
      "nct_id": "NCT02407561",
      "title": "Prospective Validation Study for the Proprietary Rectal and Anal Cancer Protein Expression Assays",
      "status": "TERMINATED",
      "phase": "",
      "condition": "Rectal Adenocarcinoma, Anal Adenocarcinoma, Anal Squamous Cell Carcinoma",
      "start_date": "2015-02",
      "completion_date": "2016-07",
      "enrollment": 0,
      "sponsor": "Castle Biosciences Incorporated"
    },
    {
      "nct_id": "NCT04213261",
      "title": "A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "condition": "Recessive Dystrophic Epidermolysis Bullosa",
      "start_date": "2020-06-09",
      "completion_date": "2037-07",
      "enrollment": 0,
      "sponsor": "Castle Creek Biosciences, LLC."
    },
    {
      "nct_id": "NCT02376920",
      "title": "5 Year Registry Study to Track Clinical Application of DecisionDx-UM Assay Results and Associated Patient Outcomes",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Uveal Melanoma",
      "start_date": "2010-03",
      "completion_date": "2022-04",
      "enrollment": 0,
      "sponsor": "Castle Biosciences Incorporated"
    },
    {
      "nct_id": "NCT00654654",
      "title": "Safety and Efficacy Study of Isolagen TherapyTM in Treatment of Facial Wrinkles and Creases",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Facial Wrinkles and Creases",
      "start_date": "2007-03",
      "completion_date": "2008-06",
      "enrollment": 0,
      "sponsor": "Castle Creek Biosciences, LLC."
    },
    {
      "nct_id": "NCT00655356",
      "title": "Safety and Efficacy Study of Isolagen Therapy in the Treatment of Nasolabial Fold Wrinkles",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Bilateral Nasolabial Fold Wrinkles",
      "start_date": "2006-11",
      "completion_date": "2009-05",
      "enrollment": 0,
      "sponsor": "Castle Creek Biosciences, LLC."
    }
  ],
  "summary": {
    "total_trials": 16,
    "by_phase": {
      "PHASE2": 5,
      "": 4,
      "PHASE3": 4,
      "PHASE2, PHASE3": 1,
      "PHASE1, PHASE2": 2
    },
    "by_status": {
      "TERMINATED": 6,
      "WITHDRAWN": 1,
      "RECRUITING": 1,
      "COMPLETED": 7,
      "ACTIVE_NOT_RECRUITING": 1
    },
    "active_trials": 2,
    "completed_trials": 7,
    "conditions": [
      "Acne Scarring of the Face",
      "Bilateral Nasolabial Fold Wrinkles",
      "Cutaneous Melanoma",
      "Dysphonia Resulting From Vocal Fold Scarring, Age-related Dysphonia",
      "Dystrophic Epidermolysis Bullosa",
      "Epidermolysis Bullosa Dystrophica, Recessive",
      "Facial Wrinkles and Creases",
      "Interdental Papillary Insufficiency",
      "Morphea, Scleroderma, Localized, Scleroderma",
      "Recessive Dystrophic Epidermolysis Bullosa",
      "Rectal Adenocarcinoma, Anal Adenocarcinoma, Anal Squamous Cell Carcinoma",
      "Restrictive Burn Scars",
      "Restrictive Burn Scars of Joint Area",
      "Uveal Melanoma"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:17:46.692130",
    "search_query": "Castle Biosciences, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Castle+Biosciences,+Inc."
  }
}